Outi Kilpivaara
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Blood donor biobank pipeline to collect genome-based samples for research.
Journal: Scientific reports
Published: October 08, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease.
Journal: Blood advances
Published: September 09, 2025
Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.
Journal: Blood advances
Published: September 09, 2025
Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.
Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.
Journal: British journal of haematology
Published: January 20, 2025
Mutational signatures and their association with cancer survival and gene expression in multiple cancer types.
Journal: International journal of cancer
Published: March 21, 2024
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.
Journal: HemaSphere
Published: February 17, 2024
Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
Journal: Frontiers in immunology
Published: June 29, 2023
Mutational signatures and their association with survival and gene expression in urological carcinomas.
Journal: Neoplasia (New York, N.Y.)
Published: June 09, 2023
The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Journal: Blood
Published: December 15, 2022
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis.
Journal: Cell reports. Medicine
Published: December 14, 2022
Last Updated: 09/26/2026